KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Incyte (INCY) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Incyte (INCY) over the last 16 years, with Q3 2025 value amounting to 32.47%.

  • Incyte's EBIT Margin rose 196300.0% to 32.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.76%, marking a year-over-year increase of 320600.0%. This contributed to the annual value of 1.45% for FY2024, which is 153400.0% down from last year.
  • Incyte's EBIT Margin amounted to 32.47% in Q3 2025, which was up 196300.0% from 43.63% recorded in Q2 2025.
  • Incyte's EBIT Margin's 5-year high stood at 43.63% during Q2 2025, with a 5-year trough of 45.81% in Q2 2024.
  • For the 5-year period, Incyte's EBIT Margin averaged around 16.32%, with its median value being 18.48% (2023).
  • As far as peak fluctuations go, Incyte's EBIT Margin soared by 1331400bps in 2021, and later crashed by -661100bps in 2024.
  • Quarter analysis of 5 years shows Incyte's EBIT Margin stood at 12.83% in 2021, then crashed by -41bps to 7.56% in 2022, then soared by 144bps to 18.48% in 2023, then surged by 38bps to 25.58% in 2024, then grew by 27bps to 32.47% in 2025.
  • Its last three reported values are 32.47% in Q3 2025, 43.63% for Q2 2025, and 19.49% during Q1 2025.